Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M W, van der Linden"'
Publikováno v:
Annals of the rheumatic diseases, 60(3), 237-241. BMJ Publishing Group
Annals of the Rheumatic Diseases, 60(3), 237-241. BMJ Publishing Group
Annals of the Rheumatic Diseases, 60(3), 237-241. BMJ Publishing Group
OBJECTIVE—Plasma concentrations of soluble CD95 (sCD95) are raised in patients with systemic lupus erythematosus (SLE) before clinical relapses become manifest. Increased sCD95 concentrations may therefore be a familial characteristic that is assoc
Autor:
M W van der Linden, M J Rood, T Q T Tong, Cornelis L. Verweij, T.W.J. Huizinga, F. C. Breedveld, S E Borggreve, V. Keijsers
Publikováno v:
Annals of the Rheumatic Diseases. 58:85-89
OBJECTIVE—To investigate the association of interleukin 10 (IL10) promoter polymorphisms and neuropsychiatric manifestations of systemic lupus erythematosus (SLE). METHODS—IL10 haplotypes of 11 healthy volunteers were cloned to confirm that in th
Autor:
H. Franssen, Krista Fischer, L. H. van den Berg, Henk M. Lokhorst, F. Schobben, M. Eurelings, L. L. Teunissen, J.M.F. Niermeijer, M. W. van der Linden, J.H.J. Wokke, Nicolette C. Notermans
Publikováno v:
Neurology, 69(1), 50-59. Lippincott Williams and Wilkins
Background: The best treatment for polyneuropathy associated with IgM monoclonal gammopathy (MGUS) is unknown. Oral cyclophosphamide combined with prednisone showed limited efficacy in a previous open label pilot study. We therefore performed a doubl
Publikováno v:
The Journal of rheumatology. 28(2)
The presence of antinuclear autoantibodies in systemic lupus erythematosus (SLE) is influenced by genetic factors. The presence of autoantibodies in healthy family members of patients has been reported. Our hypothesis was that autoantibodies are dire
Publikováno v:
Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 48(5)
Preclinical research suggests that interleukin-10 (IL-10) is associated with susceptibility to and severity of systemic lupus erythematosus. Chronic cutaneous lupus erythematosus is thought to be immunogenetically different from systemic lupus erythe
Autor:
M J, Rood, M V, van Krugten, E, Zanelli, M W, van der Linden, V, Keijsers, G M, Schreuder, W, Verduyn, R G, Westendorp, R R, de Vries, F C, Breedveld, C L, Verweij, T W, Huizinga
Publikováno v:
Arthritis and rheumatism. 43(1)
To evaluate the respective contributions of tumor necrosis factor (TNF) promoter polymorphisms and HLA-DR alleles to susceptibility to systemic lupus erythematosus (SLE).TNF-238G/A and 308G/A promoter polymorphisms and HLA-DRB1 alleles were determine
Publikováno v:
Rheumatology (Oxford, England). 38(6)
Rheumatoid arthritis (RA) and systemic lupus erythIL-10 production in human lymphocytes [6 ]. Increased ematosus (SLE) have in part overlapping clinical feaproduction of IL-10 may be of particular interest tures, but behave strikingly differently dur